|
1
|
Gonzalez-Angulo AM, Morales-Vasquez F and
Hortobagyi GN: Overview of resistance to systemic therapy in
patients with breast cancer. Adv Exp Med Biol. 608:1–22.
2007.PubMed/NCBI
|
|
2
|
Lv YG, Yu F, Yao Q, Chen JH and Wang L:
The role of survivin in diagnosis, prognosis and treatment of
breast cancer. J Thorac Dis. 2:100–110. 2010.PubMed/NCBI
|
|
3
|
Ambros V: microRNAs: Tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar
|
|
4
|
de Moor CH, Meijer H and Lissenden S:
Mechanisms of translational control by the 3′ UTR in development
and differentiation. Semin Cell Dev Biol. 16:49–58. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Blenkiron C, Goldstein LD, Thorne NP,
Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE,
Green AR, Ellis IO, et al: MicroRNA expression profiling of human
breast cancer identifies new markers of tumor subtype. Genome Biol.
8:R2142007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Silveri L, Tilly G, Vilotte JL and Le
Provost F: MicroRNA involvement in mammary gland development and
breast cancer. Reprod Nutr Dev. 46:549–556. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hui AB, Shi W, Boutros PC, Miller N,
Pintilie M, Fyles T, McCready D, Wong D, Gerster K, Waldron L, et
al: Robust global micro-RNA profiling with formalin-fixed
paraffin-embedded breast cancer tissues. Lab Invest. 89:597–606.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen X, Guo X, Zhang H, Xiang Y, Chen J,
Yin Y, Cai X, Wan K, Wang G, Ba Y, et al: Role of miR-143 targeting
KRAS in colorectal tumorigenesis. Oncogene. 28:1385–1392. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nicoloso MS, Spizzo R, Shimizu M, Rossi S
and Calin GA: MicroRNAs - the micro steering wheel of tumour
metastases. Nat Rev Cancer. 9:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hui AB, Lenarduzzi M, Krushel T, Waldron
L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O’Sullivan B,
Waldron J, et al: Comprehensive microRNA profiling for head and
neck squamous cell carcinomas. Clin Cancer Res. 16:1129–1139. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gramantieri L, Ferracin M, Fornari F,
Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E,
Grazi GL, et al: Cyclin G1 is a target of miR-122a, a microRNA
frequently downregulated in human hepatocellular carcinoma. Cancer
Res. 67:6092–6099. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hiyoshi Y, Kamohara H, Karashima R, Sato
N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M,
et al: MicroRNA-21 regulates the proliferation and invasion in
esophageal squamous cell carcinoma. Clin Cancer Res. 15:1915–1922.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma J, Dong C and Ji C: MicroRNA and drug
resistance. Cancer Gene Ther. 17:523–531. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang L, Huang J, Yang N, Greshock J,
Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR,
et al: microRNAs exhibit high frequency genomic alterations in
human cancer. Proc Natl Acad Sci USA. 103:9136–9141. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Akao Y, Nakagawa Y and Naoe T: let-7
microRNA functions as a potential growth suppressor in human colon
cancer cells. Biol Pharm Bull. 29:903–906. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park SM, Shell S, Radjabi AR, Schickel R,
Feig C, Boyerinas B, Dinulescu DM, Lengyel E and Peter ME: Let-7
prevents early cancer progression by suppressing expression of the
embryonic gene HMGA2. Cell Cycle. 6:2585–2590. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wong TS, Man OY, Tsang CM, Tsao SW, Tsang
RK, Chan JY, Ho WK, Wei WI and To VS: MicroRNA let-7 suppresses
nasopharyngeal carcinoma cells proliferation through downregulating
c-Myc expression. J Cancer Res Clin Oncol. 137:415–422. 2011.
View Article : Google Scholar :
|
|
25
|
He XY, Chen JX, Zhang Z, Li CL, Peng QL
and Peng HM: The let-7a microRNA protects from growth of lung
carcinoma by suppression of K-Ras and c-Myc in nude mice. J Cancer
Res Clin Oncol. 136:1023–1028. 2010. View Article : Google Scholar
|
|
26
|
Long XB, Sun GB, Hu S, Liang GT, Wang N,
Zhang XH, Cao PP, Zhen HT, Cui YH and Liu Z: Let-7a microRNA
functions as a potential tumor suppressor in human laryngeal
cancer. Oncol Rep. 22:1189–1195. 2009.PubMed/NCBI
|
|
27
|
Chiang AC and Massagué J: Molecular basis
of metastasis. N Engl J Med. 359:2814–2823. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Talmadge JE and Fidler IJ: AACR centennial
series: the biology of cancer metastasis: historical perspective.
Cancer Res. 70:5649–5669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Valastyan S and Weinberg RA: MicroRNAs:
Crucial multitasking components in the complex circuitry of tumor
metastasis. Cell Cycle. 8:3506–3512. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li LZ, Zhang CZ, Liu LL, Yi C, Lu SX, Zhou
X, Zhang ZJ, Peng YH, Yang YZ and Yun JP: miR-720 inhibits tumor
invasion and migration in breast cancer by targeting TWIST1.
Carcinogenesis. 35:469–478. 2014. View Article : Google Scholar
|
|
32
|
Johnson CD, Esquela-Kerscher A, Stefani G,
Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J,
Shingara J, et al: The let-7 microRNA represses cell proliferation
pathways in human cells. Cancer Res. 67:7713–7722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Meng F, Henson R, Wehbe-Janek H, Smith H,
Ueno Y and Patel T: The microRNA let-7a modulates
interleukin-6-dependent STAT-3 survival signaling in malignant
human cholangiocytes. J Biol Chem. 282:8256–8264. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mayr C, Hemann MT and Bartel DP:
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic
transformation. Science. 315:1576–1579. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu Y, Yin B, Zhang C, Zhou L and Fan J:
Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma
cell lines by targeting c-myc. Biochem Biophys Res Commun.
417:371–375. 2012. View Article : Google Scholar
|
|
36
|
Yang Q, Jie Z, Cao H, Greenlee AR, Yang C,
Zou F and Jiang Y: Low-level expression of let-7a in gastric cancer
and its involvement in tumorigenesis by targeting RAB40C.
Carcinogenesis. 32:713–722. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow
P, Chung AY, Jooi LL and Lee CG: Lethal-7 is down-regulated by the
hepatitis B virus x protein and targets signal transducer and
activator of transcription 3. J Hepatol. 53:57–66. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sampson VB, Rong NH, Han J, Yang Q, Aris
V, Soteropoulos P, Petrelli NJ, Dunn SP and Krueger LJ: MicroRNA
let-7a downregulates MYC and reverts MYC-induced growth in Burkitt
lymphoma cells. Cancer Res. 67:9762–9770. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Peluso S and Chiappetta G: High-mobility
group A (HMGA) proteins and breast cancer. Breast Care (Basel).
5:81–85. 2010. View Article : Google Scholar
|
|
40
|
Reeves R and Beckerbauer L: HMGI/Y
proteins: Flexible regulators of transcription and chromatin
structure. Biochim Biophys Acta. 1519:13–29. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fedele M and Fusco A: HMGA and cancer.
Biochim Biophys Acta. 1799:48–54. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Resar LM: The high mobility group A1 gene:
Transforming inflammatory signals into cancer? Cancer Res.
70:436–439. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dolde CE, Mukherjee M, Cho C and Resar LM:
HMG-I/Y in human breast cancer cell lines. Breast Cancer Res Treat.
71:181–191. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chiappetta G, Ottaiano A, Vuttariello E,
Monaco M, Galdiero F, Gallipoli A, Pilotti S, Jodice G, Siranoush
M, Colombo M, et al: HMGA1 protein expression in familial breast
carcinoma patients. Eur J Cancer. 46:332–339. 2010. View Article : Google Scholar
|
|
45
|
Flohr AM, Rogalla P, Bonk U, Puettmann B,
Buerger H, Gohla G, Packeisen J, Wosniok W, Loeschke S and
Bullerdiek J: High mobility group protein HMGA1 expression in
breast cancer reveals a positive correlation with tumour grade.
Histol Histopathol. 18:999–1004. 2003.PubMed/NCBI
|
|
46
|
Masciullo V, Baldassarre G, Pentimalli F,
Berlingieri MT, Boccia A, Chiappetta G, Palazzo J, Manfioletti G,
Giancotti V, Viglietto G, et al: HMGA1 protein over-expression is a
frequent feature of epithelial ovarian carcinomas. Carcinogenesis.
24:1191–1198. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xu Y, Sumter TF, Bhattacharya R, Tesfaye
A, Fuchs EJ, Wood LJ, Huso DL and Resar LM: The HMG-I oncogene
causes highly penetrant, aggressive lymphoid malignancy in
transgenic mice and is overexpressed in human leukemia. Cancer Res.
64:3371–3375. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chiappetta G, Manfioletti G, Pentimalli F,
Abe N, Di Bonito M, Vento MT, Giuliano A, Fedele M, Viglietto G,
Santoro M, et al: High mobility group HMGI(Y) protein expression in
human colorectal hyperplastic and neoplastic diseases. Int J
Cancer. 91:147–151. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Abe N, Watanabe T, Masaki T, Mori T,
Sugiyama M, Uchimura H, Fujioka Y, Chiappetta G, Fusco A and Atomi
Y: Pancreatic duct cell carcinomas express high levels of high
mobility group I(Y) proteins. Cancer Res. 60:3117–3122.
2000.PubMed/NCBI
|
|
50
|
Chiappetta G, Tallini G, De Biasio MC,
Manfioletti G, Martinez-Tello FJ, Pentimalli F, de Nigris F, Mastro
A, Botti G, Fedele M, et al: Detection of high mobility group I
HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y)
expression represents a potential diagnostic indicator of
carcinoma. Cancer Res. 58:4193–4198. 1998.PubMed/NCBI
|
|
51
|
Hillion J, Wood LJ, Mukherjee M,
Bhattacharya R, Di Cello F, Kowalski J, Elbahloul O, Segal J,
Poirier J, Rudin CM, et al: Upregulation of MMP-2 by HMGA1 promotes
transformation in undifferentiated, large-cell lung cancer. Mol
Cancer Res. 7:1803–1812. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Tamimi Y, van der Poel HG, Denyn MM, Umbas
R, Karthaus HF, Debruyne FM and Schalken JA: Increased expression
of high mobility group protein I(Y) in high grade prostatic cancer
determined by in situ hybridization. Cancer Res. 53:5512–5516.
1993.PubMed/NCBI
|
|
53
|
Tesfaye A, Di Cello F, Hillion J, Ronnett
BM, Elbahloul O, Ashfaq R, Dhara S, Prochownik E, Tworkoski K,
Reeves R, et al: The high-mobility group A1 gene up-regulates
cyclooxygenase 2 expression in uterine tumorigenesis. Cancer Res.
67:3998–4004. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Rho YS, Lim YC, Park IS, Kim JH, Ahn HY,
Cho SJ and Shin HS: High mobility group HMGI(Y) protein expression
in head and neck squamous cell carcinoma. Acta Otolaryngol.
127:76–81. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hornstein E, Mansfield JH, Yekta S, Hu JK,
Harfe BD, McManus MT, Baskerville S, Bartel DP and Tabin CJ: The
microRNA miR-196 acts upstream of Hoxb8 and Shh in limb
development. Nature. 438:671–674. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wightman B, Ha I and Ruvkun G:
Posttranscriptional regulation of the heterochronic gene lin-14 by
lin-4 mediates temporal pattern formation in C. elegans. Cell.
75:855–862. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
